MDL 3094 | Eastern District of Pennsylvania
Ozempic Lawsuit MDL 3094 Case Management Orders (CMOs)
Every case management order (CMO) entered in the Ozempic lawsuits consolidated in MDL 3094, newest first.
Last updated:
MDL 3094 has been in existence since February 2024, and there are now dozens of case management orders on file. Ozempic lawsuits have been filed around the country alleging that the drug caused bowel obstructions and other gastrointestinal (GI) disorders. Reading the orders is one of the best ways to follow the status of the litigation. Bookmark this page: new orders are added once they are entered on the MDL 3094 docket.
MDL 3094 At A Glance
- MDL
- In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094
- Court
- U.S. District Court, Eastern District of Pennsylvania
- Case No.
- 2:24-md-03094 (KSM)
- Presiding Judge
- Hon. Karen Spencer Marston, U.S.D.J.
- Centralized
- February 2, 2024 (Judicial Panel on Multidistrict Litigation transfer order)
- Latest Order
- Order Rescheduling October Status Conference & Setting Closing Arguments on Rule 702 (October 8, 2026)
All MDL 3094 Case Management Orders
31 orders listed. Jump to a year:
2026
-
Order Rescheduling October Status Conference & Setting Closing Arguments on Rule 702 (Cross-Cutting Issues 2 and 3) PDF
-
Amended Order Regarding Status Conferences PDF
-
Case Management Order No. 32 Fifth Amended Scheduling Order for Cross-Cutting Issues PDF
-
Case Management Order No. 31 Fourth Amended Scheduling Order for Cross-Cutting Issues 2 and 3 PDF
-
Case Management Order No. 30 Establishment of Streamlined Docket PDF
-
Case Management Order No. 29 Third Amended Scheduling Order for Cross-Cutting Issues 2 and 3 PDF
-
Case Management Order No. 28 Second Amended Scheduling Order for Cross-Cutting Issues 2 and 3 PDF
2025
-
Case Management Order No. 27 Short Form Complaint Enabling Order PDF
-
Case Management Order No. 26 Plaintiffs’ Production of Electronically Stored Information (ESI) PDF
-
Case Management Order No. 25 Coordination Order for Related Actions PDF
-
Case Management Order No. 24 Deposition Protocol for Non-Experts PDF
-
Case Management Order No. 23 Amended Scheduling Order for Cross-Cutting Issues 2 and 3 PDF
2024
-
Case Management Order No. 22 Scheduling Order for Motion to Dismiss the Master Complaint PDF
-
Status Conference Scheduling Order PDF
-
Case Management Order No. 21 Amended Scheduling Order for Cross-Cutting Issue No. 1 PDF
-
Case Management Order No. 20 Discovery, Rule 702, and Summary Judgment Schedule for Cross-Cutting Issues 2 and 3 PDF
-
Case Management Order No. 19 Rule 702 Schedule for Cross-Cutting Issue No. 1 PDF
-
Case Management Order No. 18 Cross-Cutting Issues PDF
-
Case Management Order No. 17 Time and Expense Protocol & Common Benefit Funds PDF
-
Case Management Order No. 16 Special Master Appointment and Discovery Protocol PDF
-
Case Management Order No. 15 ESI Protocol PDF
-
Case Management Order No. 14 Direct Filing Order PDF
-
Case Management Order No. 13 Dismissal of Claims Against Certain Novo Defendants PDF
-
Case Management Order No. 12 Plaintiff Fact Sheets Protocol PDF
-
Case Management Order No. 11 Qualified Protective Order & Sealing Process PDF
-
Case Management Order No. 10 Rule 502(d) Order PDF
-
Case Management Order No. 9 Privilege Logging Order PDF
-
Case Management Order No. 8 Pro Hac Vice PDF
-
Case Management Order No. 7 Status Conference on June 10, 2024, with Honorable Karen Marston PDF
-
Case Management Order No. 6 Expansion of Plaintiffs’ Leadership PDF
-
Case Management Order No. 5 Science Day (Vacated) PDF
-
Case Management Order No. 4 Preservation Order PDF
-
Case Management Order No. 3 Initial Appointments of Plaintiffs’ Leadership PDF
-
Case Management Order No. 2 Pro Hac Vice Appearances PDF
-
Case Management Order No. 1 Initial Organizational Conference for Counsel with the Court and Related Preliminary Matters PDF
-
JPML Transfer Order Creation of MDL 3094 PDF
Court Notices (Eastern District of Pennsylvania)
The following general notices from the Eastern District of Pennsylvania, where MDL 3094 is pending, are provided for reference.
-
Anti-Discrimination and Harassment Notice Eastern District of Pennsylvania PDF
-
Employment Dispute Resolution (EDR) Plan Eastern District of Pennsylvania PDF
Ozempic Lawsuit MDL 3094 Information
For more information on the status of MDL 3094, visit our page on the Ozempic Lawsuit. For more background on the litigation, see the details below.
What is MDL 3094?
MDL 3094 is a multidistrict litigation created by the Judicial Panel on Multidistrict Litigation (JPML) on February 2, 2024. It consolidates Ozempic lawsuits filed in federal courts around the country before a single judge in the Eastern District of Pennsylvania for coordinated pretrial proceedings. The litigation is captioned In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation.
What do the Ozempic lawsuits allege?
Plaintiffs allege that Ozempic caused bowel obstructions and other gastrointestinal disorders, and that the drug’s manufacturers failed to adequately warn about these risks.
What are case management orders?
Case management orders (CMOs) are rulings entered by the court that set the rules and schedule for the MDL. They cover leadership appointments, discovery protocols, filing procedures, scheduling, and other matters. Reviewing them is a good way to follow the progress of MDL 3094.
What are “cross-cutting issues” in MDL 3094?
Several orders on this page set schedules for “cross-cutting issues,” which are questions that apply across many cases in the MDL rather than to any one plaintiff. The most recent order sets closing arguments on Rule 702 for Cross-Cutting Issues 2 and 3. Rule 702 is the federal rule governing the admissibility of expert testimony.
Free Consultation
For a free consultation with our Ozempic attorneys, please call 202-792-7927 or contact us today.
